Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Ducharme, Anique, Swedberg, Karl, Pfeffer, Marc A., Cohen-Solal, Alain, Granger, Christopher B., Maggioni, Aldo P., Michelson, Eric L., McMurray, John J.V. +6 more·2006·American Heart Journal
DOI 10.1016/j.ahj.2005.06.036

Cited by (351)

Items 301–351 of 351

  1. Fixed combinations in modern hypertension treatment algorithms
    E. V. Sayutina · 2018 · CARDIOVASCULAR THERAPY AND PREVENTION
  2. Curative effect of β‑blocker on various ejection fractions of patients with atrial fibrillation
    Wei Cao, Likun Ma · 2019 · Experimental and Therapeutic Medicine
  3. Comparison of the Hydride-Donating Ability and Activity of Five- and Six-Membered Benzoheterocyclic Compounds in Acetonitrile
    Jinye Zhang, Xiao‐Qing Zhu · 2022 · Molecules
  4. Blockade of renin–angiotensin system: A supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation
    Shimo Dai, Shu Zhang, Jianmin Chu, Yinghua Guo, Keping Chen, Shu‐Yuan Yao · 2007 · Medical Hypotheses
  5. Angiotensin II does not influence expression of sarcoplasmic reticulum Ca2 + ATPase in atrial myocytes
    Cho‐Kai Wu, Chuen-Den Tseng, Yin-Tsen Huang, Chia-Shan Hsieh, Wei-Shan Tsai, Jiunn-Lee Lin, Fu‐Tien Chiang, Chia‐Ti Tsai · 2009 · Journal of the Renin-Angiotensin-Aldosterone System
  6. Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
    Arnljot Tveit, Irene Grundvold, Mona Olufsen, Ingebjørg Seljeflot, Michael Abdelnoor, Harald Arnesen, Pål Smith · 2007 · International Journal of Cardiology
  7. AB18-5
    Bernhard Richter, Marianne Gwechenberger, Magdalena Kapitan, Manfred Marx, Peter Lercher, H. Goessinger · 2006 · Heart Rhythm
  8. Novel Personalised Determinants of Atrial Substrate in Atrial Fibrillation
    Geoffrey R. Wong · 2019 · Minerva Access (University of Melbourne)
  9. Electrophysiological Substrates of Atrial Fibrillation: A Frequency Domain Study of Intra-cardiac Electrograms
    Jiun Tuan · 2011 · Figshare
  10. Atrial remodeling in atrial fibrillation : Epidemiological, clinical and magnetocardiographic aspects
    Mika Lehto · 2009 · Työväentutkimus Vuosikirja
  11. Upstream Therapy in the Treatment of Atrial Fibrillation
    Cristian Băicuş · 2013 · Springer eBooks
  12. Klinische Studien/Klinische Praxis: Das Angiotensin-System und Effekte seiner Inhibierung beim Vorhofflimmern - Die Rolle von Candesartan
    Johann Auer · 2007 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  13. Novel Pharmacological Targets for the Management of Atrial Fibrillation
    Alexander Burashnikov, Charles N Antzelevitch · 2009
  14. Fármacos para control de la frecuencia ventricular y fármacos no-antiarrítmicos en fibrilación auricular
    Vicens Martí C, Leonel Markarian · 2007 · Revista Portuguesa de Pneumologia
  15. Clinical benefits from combination therapy in the treatment of hypertension
    Roberto Fogari, Annalisa Zoppi · 2010 · Hipertensión y Riesgo Vascular
  16. Beneficios adicionales del tratamiento con candesartán en la insuficiencia cardíaca. Programa CHARM
    Vivencio Barrios, Carlos Escobar, A. Calderón · 2007 · Hipertensión
  17. Gaps in the ARB Knowledge Base: Are ARBs Effective Anti–Atrial Fibrillation Agents?
    Peter Russell Kowey · 2009 · Journal of Clinical Hypertension
  18. Perspectivas futuras del tratamiento con antagonistas de los recepetores de la angiotensina
    Alejandro de la Sierra · 2007 · Hipertensión
  19. Importancia de la prevención de la fibrilación auricular en el paciente hipertenso
    C. Roldán Suárez, Juan Pablo Tomás, José Antonio García Donaire, J. Segura de la Morena · 2007 · Hipertensión y Riesgo Vascular
  20. Atrial Fibrillation and Heart Failure Syndromes
    Lynne K. Williams, Gregory Y.H. Lip, Robert J. MacFadyen · 2010 · Springer eBooks
  21. Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
    Virendra K. Misra, Wael A. Almahmeed · 2014 · Ibnosina Journal of Medicine and Biomedical Sciences
  22. Angiotensin II receptors blockers in the treatment of patients with cardiorenal syndrome
    Насыбуллина Алсу Анваровна, O. V. Bulashova, Elena Vladimirovna Khazova, V. M. Gazizyanova, MARIA I. MALKOVA · 2015 · Kazan medical journal
  23. Insuficiência Cardíaca: do Tratamento Farmacológico à Terapia-Celular
    Milton Artur Ruiz, Oswaldo Tadeu Greco, José Luiz Balthazar Jacob, Roberto Vito Ardito, Mario Roberto Lago, Rafael Lois Greco, Adriana Barbosa Santos, Lílian Piron Ruiz, Alana F. C. Poloni · 2007 · DOAJ (DOAJ: Directory of Open Access Journals)
  24. PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
    Sergey Anatol'evich Boytsov, Колос Игорь Петрович · 2008 · Rational Pharmacotherapy in Cardiology
  25. Grupo de Trabajo para el manejo de la hipertensión arterial de la Sociedad Europea de Hipertensión (ESH) y la Sociedad Europea de Cardiología (ESC)
    Giuseppe Mancia, Robert H. Fagard · 2016
  26. Илья Клейнер «Портрет Иосифа Бродского» Факторы риска развития фибрилляции предсердий. Современные подходы к лечению
    Natalya Novikova · 2010 · CyberLeninK (CyberLeninka)
  27. Non-antiarrhythmic Therapies for Cardiac Arrhythmias
    PRAKASH C. DEEDWANIA, Joel A. Lardizabal · 2012 · Elsevier eBooks
  28. Effective inhibition of renin-angiotensin-aldosterone system: the angiotensin-converting enzyme inhibitors benefits
    Сергей Валентинович Столов · 2014 · HYPERTENSION
  29. UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
    Протасова Елена Анатольевна, Н. В. Фурман, O. V. Reshetko · 2012 · Rational Pharmacotherapy in Cardiology
  30. Europejskie zalecenia dotyczące leczenia nadciśnienia tętniczego: stanowisko Europejskiego Towarzystwa Nadciśnienia Tętniczego 2009
    Giuseppe Mancia, Stéphane Laurent, Enrico Agabiti‐Rosei, Ettore Ambrosioni, Michel Burnier, Mark J. Caulfield, Renata Cífková, Denis L Clement, António Coca, Anna F. Dominiczak et al. · 2010 · Arterial Hypertension
  31. Drug therapy for atrial fibrillation: quo vadis?
    Ronald Jardine · 2017 · SA Heart
  32. Effekte eines körperlichen Trainingsprogrammes auf die diastolische Funktion und die Leistungsfähigkeit bei Patienten mit diastolischer Herzinsuffizienz
    Stefan Fröhling · 2012
  33. Atrial Fibrillation
    James A. McCaffrey, Cynthia M. Tracy · 2017 · Circulation Arrhythmia and Electrophysiology
  34. Practical aspects of anticoagulant therapy in patients with atrial fibrillation and arterial hypertension
    Zhanna D. Kobalava, Шаваров Андрей Анатольевич · 2018 · Kardiologiia
  35. Pharmacological stroke prevention: RAS inhibitors
    Ole Dyg Pedersen, Christian Tobias Torp-Pedersen · 2012
  36. Ilya Kleiner «The Portrait of Iosif Brodsky». Risk factors for atrial fibrillation: Modern views on treatment
    Т. N. Novikova · 2010 · Arterial’naya Gipertenziya (Arterial Hypertension)
  37. Novel pharmacological strategies for antiarrhythmic therapy in atrial fibrillation
    Zsófia Kohajda, Kristóf Attila, Attila Kristóf, Claudia Corici, László Virág, Danina Mirela Muntean, M. Muntean Danina, András Varró, Norbert Jost, J Laszlo · 2011 · SZTE Publicatio Repozitórium (University of Szeged)
  38. Antiarrhythmic Properties of Non-Antiarrhythmic Drugs in Atrial Fibrillation: Upstream Therapy
    Alina Scridon, Antoni Martínez‐Rubio · 2020 · Springer eBooks
  39. Elevated chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes was observed in the patient of atrial fibrillation
    Keisuke Okamura, Tetsu Okuda, Yosuke Takamiya, Kazuyuki Shirai, Hidenori Urata · 2020 · Heart and Vessels
  40. Importancia de la prevención de la fibrilación auricular en el paciente hipertenso
    C. Roldán Suárez, Juan Pablo Tomás, José Antonio García Donaire, J. Segura de la Morena · 2007 · Hipertensión
  41. Perspectives of using angiotensin receptor antagonists
    Victor Fomin · 2009 · Systemic Hypertension
  42. Heart Failure as a Consequence of Hypertension
    Florian Rader, Ronald G. Victor · 2020 · Elsevier eBooks
  43. The significance of different biomarkers in the prediction of the development of atrial fibrillation after cardiac surgery
    Diana Sudavičienė · 2014
  44. Usefulness of upstream therapy with renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation in patients with heart failure
    Masami Murakami, Shinichi Niwano, Akira Satoh, Shoko Ishikawa, Jun Kishihara, Yuya Aoyama, Hiroe Niwano, Tohru Izumi · 2012 · Kitasato medical journal
  45. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: which class of drugs should be preferable for patients with cardiovascular pathology?
    Сергей Валентинович Столов, Привалов Константин Александрович · 2021 · HERALD of North-Western State Medical University named after I I Mechnikov
  46. HYPERTENSION AND ATRIAL FIBRILLATION: RECENT ADVANCES
    Serviço de Eletrofisiologia da Angiocorpore. Santos, SP, Brasil, Juliana Filgueiras Medeiros, Cristiano de Oliveira Dietrich, Rafael Thiesen Magliar, Fábio Martins Nardo Botelho, Lucas Hollanda Oliveira, Christian Moreno Luize, Ricardo Sobral, Alberto Borga Medeiros, Ângelo Amato Vicenzo de Paola et al. · 2021 · Revista Brasileira de Hipertensão
  47. How Does Atrial Fibrillation Cause Development of Atrial Thrombosis and Subsequent Thromboembolism?
    Vincent J.B. Robinson, Gyanendra K. Sharma, Rohan S. Sharma, Lauren Chow, James Harris Calhoun, Mikhil Patel, Soham Kulkarni, K B Li, Jeffrey A. Switzer · 2024 · Cardiology and cardiovascular medicine.
  48. Non-antiarrhythmic Drugs with Antiarrhythmic Properties
    Alina Scridon, Andreea Cristina Ivănescu, Vasile-Bogdan Halațiu · 2024 · Springer eBooks
  49. Identifying atrial fibrillation associated chemicals by integrating transcriptome-wide association study and chemical-gene interaction networks
    Botao Li, Su Yun Hu, Lei Jiang, Chong Lu, Wu Wei, Jing Liu · 2025 · Research Square
  50. Atrial Fibrillation and HFrEF: Cause, Consequence, or Both?
    Mihai Grigore, Andreea-Maria Grigore, R E Martin-Graur, Camelia Nicolae, Ana-Maria Balahura, Ioana Verde, Gabriela Uscoiu, Adriana-Mihaela Ilieșiu · 2026 · Biomedicines
  51. Experimental studies on new therapeutic approaches in atrial fibrillation
    Dominik Linz · 2013